Startseite
Reels
Gruppen
Seiten
Mehr sehen
Gruppen Seiten Veranstaltungen Blogs Spendenaufruf
Anmelden Registrieren
Nachtmodus
How Are Disease-Modifying Biologics Transforming Pulmonary Arterial Hypertension Treatment?
For decades, PAH treatment relied on vasodilators that managed symptoms but did not address the underlying disease process. Disease-modifying biologics are transforming PAH treatment by targeting the vascular remodeling that drives disease progression, offering the potential for improved long-term outcomes. This innovation is a major driver of growth in the Pulmonary Arterial Hypertension...
0 Kommentare ·0 Geteilt ·135 Ansichten ·0 Bewertungen
Bitte loggen Sie sich ein, um liken, teilen und zu kommentieren!